SCHEMBL6945893

SCHEMBL6945893

CCCC1=NN(c2ccccc2C(=O)O)C(=O)C1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 1/20 0.52
GAA P10253 4/20 0.45
ALDH1A1 P00352 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 3/20 0.40
MYC P01106 3/20 0.40
NR4A1 P22736 1/20 0.40
TSHR P16473 1/20 0.39
KDM4E B2RXH2 3/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
ALOX15 P16050 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8423942 0.86 ALDH1A1 (0.43) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL14559419 0.81 SHMT2 (0.54) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL14559423 0.80 SHMT2 (0.52) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL13931173 0.79 KMT2A (0.59) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL6951653 0.71 CD274 (0.62) SHMT2GAAALDH1A1L3MBTL1KDM4E
SCHEMBL14559417 0.71 SHMT2 (0.77) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL5976250 0.70 SHMT2 (0.62) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL14559428 0.69 SHMT2 (0.43) SHMT2GAAALDH1A1MEN1KMT2A
SCHEMBL6949830 0.69 SHMT2 (0.60) SHMT2GAAALDH1A1L3MBTL1MEN1
SCHEMBL6953514 0.68 SHMT2 (0.58) SHMT2GAAALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed